Skip to main content

Table 1 List and information of cases studied

From: Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

Case year

Case num

Age

Sex

MMSE

PMI

APOE

NPDx1

NPDx2

Braak tangle stage

Braak plaque stage

2003

9

81

M

27

6.4

2/3

N/MBC

 

II

0

2006

34

79

M

N/A

3.52

2/4

N/MBC

Other

V

B

2005

32

89

F

24

3.58

3/3

N/MBC

 

III

B

2004

30

90

F

30

3.8

3/3

N/MBC

Other

IV

B

2005

12

78

M

12

2.8

3/4

N/MBC

DLBD

III

B

2005

13

94

F

N/A

5.92

 

N/MBC

 

I

A

1997

27

66

M

N/A

13.37

N/A

N/MBC

 

N/A

N/A

1997

32

68

M

N/A

2.43

N/A

N/MBC

 

N/A

N/A

1999

10

70

M

N/A

5.2

N/A

N/MBC

 

N/A

N/A

2004

8

75

F

N/A

10.5

3/3

N/MBC

VD

II

0

2003

4

83

M

28

12.4

4/4

N/MBC

VD

III

0

2002

17

74

M

14

2.6

3/4

N/MBC

VD

II

A

2001

20

85

M

15

3.2

2/4

N/MBC

VD

III

0

2001

14

73

M

N/A

4.3

3/3

N/MBC

VD

0

0

2006

1

63

M

10

5.8

3/4

AD

 

VI

C

2006

21

82

M

16

4.7

3/4

AD

 

VI

C

2004

10

71

M

3

6.4

3/3

AD

 

VI

C

2004

44

96

F

N/A

4.3

3/4

AD

 

VI

C

2004

46

94

F

N/A

26.92

2/3

AD

 

VI

C

2005

31

79

M

6

6

3/4

AD

 

VI

C

2007

15

75

M

18

5.08

3/4

AD

 

VI

C

2008

3

72

M

0

8.25

4/4

AD

 

VI

C

2008

4

68

M

3

4.83

3/4

AD

 

VI

C

2001

12

61

F

N/A

2.8

3/4

AD

 

VI

C

2001

18

74

F

N/A

4.5

3/4

AD

 

VI

C

  1. AD, Alzheimer’s disease; MMSE, score for the Mini Mental Status Exam; N/A, not available; N/MBC, normal mild Braak changes; NPDx1, neuropathological diagnosis; NPDx2, secondary neuropathological diagnosis; PMI, post mortem interval in hours; VD, vascular dementia.